RESUMEN
Agriculture needs to decrease the use of agrochemicals due to their high toxicity and adopt new strategies to achieve sustainable food production. Therefore, nanoparticles (NPs) and plant growth-promoting bacteria (PGPB) have been proposed as viable strategies to obtain better crop yields with less environmental impact. Here, we describe the effect of silica nanoparticles (SiO2-NPs) on survival, antioxidant enzymatic activity, phosphate solubilization capacity, and gibberellin production of Bacillus cereus-Amazcala (B.c-A). Moreover, the effect of the co-application of SiO2-NPs and B.c-A on seed germination, physiological characteristics, and antioxidant enzymatic activity of chili pepper plants was investigated under greenhouse conditions. The results indicated that SiO2-NPs at 100 ppm enhanced the role of B.c-A as PGPB by increasing its phosphate solubilization capacity and the production of GA7. Moreover, B.c-A catalase (CAT) and superoxide dismutase (SOD) activities were increased with SiO2-NPs 100 ppm treatment, indicating that SiO2-NPs act as a eustressor, inducing defense-related responses. The co-application of SiO2-NPs 100 ppm and B.c-A improved chili pepper growth. There was an increase in seed germination percentage, plant height, number of leaves, and number and yield of fruits. There was also an increase in CAT and PAL activities in chili pepper plants, indicating that bacteria-NP treatment induces plant immunity.
RESUMEN
INTRODUCTION: Monkeypox virus (MPXV) is an enveloped double-stranded DNA virus with a genome of approximately 197.209 bp. The current classification divides MPXV into three clades: Clade I (Central African or Congo Basin clade) and clades IIa and IIb (West African clades). OBJECTIVE: To report the complete genome and phylogenetic analysis of a human monkeypox case detected in Colombia. MATERIALS AND METHODS: Exudate from vesicular lesions was obtained from a male patient with recent travel history to Spain. A direct genomic approach was implemented in which total DNA from the sample was purified through a column-based method, followed by sequencing on the Nanopore GridION. Reads were aligned against the MPXV reference genome using minimap2 v.2.24 and phylogenetic inference was performed using maximum likelihood estimation. RESULTS: A total of 11.951 reads mapped directly to a reference genome with 96.8% of coverage (190.898 bp). CONCLUSION: Phylogenetic analysis of the MPXV circulating in Colombia demonstrated its close relationship to clade IIb responsible for the multi-country outbreak in 2022.
Introducción. El virus de la viruela del mono (MPXV) está compuesto por un genoma de ADN bicatenario, aproximadamente, de 197.209 pb. La clasificación actual agrupa el MPXV en tres clados: clado I (de la cuenca del Congo en África central), y clados IIa y IIb (de África occidental). Objetivo. Reportar el genoma completo y el análisis filogenético de un caso humano de viruela símica detectado en Colombia. Materiales y métodos. Se obtuvo exudado de lesiones vesiculares de un paciente varón con el antecedente de un viaje reciente a España. Se implementó un enfoque directo, en el cual se purificó el ADN total de la muestra mediante un método basado en columnas, seguido de la secuenciación directa en la plataforma Nanopore GridION. Las lecturas se alinearon con el genoma de referencia del MPXV, utilizando minimap2, v.2.24, y la inferencia filogenética fue realizada mediante la estimación por máxima verosimilitud. Resultados. Un total de 11.951 lecturas se alinearon directamente con el genoma de referencia con una cobertura del 96,8 % (190.898 pb). Conclusión. El análisis filogenético del MPXV circulante en Colombia demostró su estrecha relación con el clado de África occidental (clado IIb) responsable del brote en múltiples países en el 2022.
Asunto(s)
Monkeypox virus , Mpox , Colombia , Humanos , Masculino , Mpox/diagnóstico , Mpox/epidemiología , Mpox/patología , Monkeypox virus/genética , Filogenia , Análisis de Secuencia de ADNRESUMEN
Zika virus is an arthropod-borne virus that has recently emerged as a significant public health emergency due to its association with congenital malformations. Serological and molecular tests are typically used to confirm Zika virus infection. These methods, however, have limitations when the interest is in localizing the virus within the tissue and identifying the specific cell types involved in viral dissemination. Chromogenic in situ hybridization (CISH) and immunohistochemistry (IHC) are common histological techniques used for intracellular localization of RNA and protein expression, respectively. The combined use of CISH and IHC is important to obtain information about RNA replication and the location of infected target cells involved in Zika virus neuropathogenesis. There are no reports, however, of detailed procedures for the simultaneous detection of Zika virus RNA and proteins in formalin-fixed paraffin-embedded (FFPE) samples. Furthermore, the chromogenic detection methods for Zika virus RNA published thus far use expensive commercial kits, limiting their widespread use. As an alternative, we describe here a detailed and cost-effective step-by-step procedure for the simultaneous detection of Zika virus RNA and proteins in FFPE samples. First, we describe how to synthesize and purify homemade RNA probes conjugated with digoxygenin. Then, we outline the steps to perform the chromogenic detection of Zika virus RNA using these probes, and how to combine this technique with the immunodetection of viral antigens. To illustrate the entire workflow, we use FFPE samples derived from infected Vero cells as well as from human and mouse brain tissues. These methods are highly adaptable and can be used to study Zika virus or even other viruses of public health relevance, providing an optimal and economical alternative for laboratories with limited resources. © 2021 Wiley Periodicals LLC. Basic Protocol 1: Synthesis of RNA probes conjugated with digoxigenin (DIG) Basic Protocol 2: Simultaneous detection of ZIKV RNA and proteins in FFPE cell blocks and tissues.
Asunto(s)
Infección por el Virus Zika , Virus Zika , Animales , Chlorocebus aethiops , Formaldehído , Inmunohistoquímica , Hibridación in Situ , Ratones , Adhesión en Parafina , ARN , Células Vero , Virus Zika/genética , Infección por el Virus Zika/diagnósticoRESUMEN
Oxidative stress (OS) increases during the human aging process, and the sedentary lifestyle could be a prooxidant factor. In this study, we determine the effect of sedentary lifestyle on OS during the aging process in Mexican women. A longitudinal study of two-year follow-up was carried out with 177 community-dwelling women (40-69 y) from Mexico City. We measured as OS markers plasma malondialdehyde, erythrocyte glutathione peroxidase (GPx) and superoxide dismutase (SOD), total plasma antioxidant status, uric acid level, antioxidant gap, and SOD/GPx ratio. To define OS using all the markers, we defined cut-off values of each parameter based on the 90th percentile of young healthy subjects and, we calculated a stress score (SS) ranging from 0 to 7, which represented the intensity of the marker modifications. All the women answered a structured questionnaire about prooxidant factors, including physical activity specially the type of activity, frequency, and duration, and they answered Spanish versions of self-assessment tests for establishing dysthymia and insomnia as potential confounders. Principal component and Poisson regression analysis were used as statistical tools, being two-year OS the primary outcome. The OS was considerate as SS ≥ 4 and sedentary lifestyle as <30 min/day of physical activity, beside several prooxidant factors and age that were covariables. SS is higher in sedentary lifestyle women after the two-year follow-up; although, the difference was statistically significant only in older women. Four principal components were associated with the OS, and 7 out of 8 prooxidant factors were important for the analysis, which were included in the Poisson model. The predictive factors for OS were the sedentary lifestyle (adjusted PR = 2.37, CI95%: 1.30-4.30, p < 0.01), and age, in which the risk increases 1.06 (CI95%:1.02-2.11, p < 0.01) by each year of age. Our findings suggest that a sedentary lifestyle increases the OS during the aging in Mexican women.
Asunto(s)
Envejecimiento , Antioxidantes/metabolismo , Trastorno Distímico/epidemiología , Ejercicio Físico , Estrés Oxidativo , Conducta Sedentaria , Trastornos del Inicio y del Mantenimiento del Sueño/epidemiología , Adulto , Anciano , Biomarcadores/metabolismo , Femenino , Humanos , Estudios Longitudinales , México/epidemiología , Persona de Mediana EdadRESUMEN
OBJECTIVE: To assess the association between hot flashes (HFs) severity and oxidative stress (OS) in Mexican postmenopausal women. METHODS: A cross-sectional study was carried out with perimenopausal women aged 40-59 years community-dwelling from Mexico City, Mexico. They participated in Menopause and Oxidative Stress Project. The baseline sample consisted of 476 women recruited to participate; 161 women were excluded due to different reasons. Hence, 315 women were selected to establish two groups, a) 145 premenopausal women (yet with menstrual bleeding), and b) 170 postmenopausal women (without menses). All women were free of cardiovascular, kidney, hepatic or cancer disease, and without antioxidant supplement intake for at least six months prior to the beginning of the study; none had previously received hormone therapy. As OS markers, we measured plasma malondialdehyde using the TBARS assay, erythrocyte superoxide dismutase (SOD) and glutathione peroxidase (GPx), uric acid, and total antioxidant status; also, we calculated SOD/GPx ratio, antioxidant gap and an oxidative stress score ranging from 0 to 7. The HFs were evaluated using the Menopause Rating Scale. The women completed Spanish version of the Athens Insomnia Scale, Zung Self-Rating Anxiety Scale and Zung Self-Rating Depression Scale and a questionnaire of pro-oxidant factors. RESULTS: Stress score increased with HFs severity (mild 2.7±0.17, moderate 2.9±0.20 and severe 3.7±0.20, p = 0.001) in postmenopausal women. We observed a positive correlation between HFs severity and stress score, r = 0.247 (p = 0.001) in postmenopausal women; other test scores were not correlated. Severe HFs were a risk factor for OS (OR = 5.12, 95%CI: 1.99-13.17, p<0.05) in an adjusted multivariate analysis by different postmenopausal symptoms and pro-oxidant factors; we did not see any association in premenopausal women. CONCLUSION: Our findings suggest an association between HFs severity and OS in Mexican postmenopausal women.
Asunto(s)
Sofocos/sangre , Estrés Oxidativo , Posmenopausia/sangre , Adulto , Femenino , Glutatión Peroxidasa/sangre , Sofocos/epidemiología , Sofocos/fisiopatología , Humanos , Malondialdehído/sangre , México , Persona de Mediana Edad , Posmenopausia/fisiología , Superóxido Dismutasa/sangre , Ácido Úrico/sangreRESUMEN
BACKGROUND: Menopause is the onset of aging in women. During this process, some women experience physical changes that may impact upon their psychological and social status, also affecting their quality of life. Furthermore, several psychological changes following menopause have been shown to act as pro-oxidant, but the association between the psychological status that modify the quality of life and oxidative stress in postmenopausal women is still unclear. The aim of this study was to determinate the relationship between oxidative stress with psychological disturbances, low self-esteem, depressive mood and anxiety, and quality of life in the postmenopausal women. METHODS: We carried out a cross-sectional study with101 premenopausal and 101 postmenopausal women from Mexico City. As markers of oxidative stress we measured plasma lipoperoxide levels, erythrocyte superoxide dismutase and glutathione peroxidase activities, and total antioxidant status. We calculate a stress score as global oxidative stress status, with cut-off values for each parameter; this score range from 0 to 6, representing the severity of markers modifications. All the women were rated using the Coopersmith Self-Esteem Inventory, the Zung Self-Rating Anxiety and the Zung Self-Rating Depression Scales, and the WHO Quality of Life-brief. RESULTS: The postmenopausal women with low quality of life in the WHO Quality of Life-brief and their subscales had higher stress score compared with premenopausal women with high quality of life (p < 0.05). We found a positive correlation among lipoperoxide levels and Zung Self-Rating Anxiety and Zung Self-Rating Depression score (r = 0.226 and r = 0.173, respectively, p < 0.05), and a negative correlation with WHO Quality of Life-brief scores (r = -0.266, p < 0.01) in postmenopausal women. Multiple linear regression analysis revealed that average lipoperoxide levels increase by 0.0007 µmol/L for every 1-point increase in the Coopersmith Self-Esteem Inventory and by 0.001 µmol/L for every 1-point decrease in the WHO Quality of Life-brief, after adjusted for pro-oxidant factors. Zung Self-Rating Anxiety and Zung Self-Rating Depression Scales scores also contribute to increase lipoperoxides levels, but not significant. CONCLUSION: Our findings suggest that oxidative stress is increased in postmenopausal women with psychological disturbances and low quality of life.
Asunto(s)
Menopausia/psicología , Estrés Oxidativo , Calidad de Vida/psicología , Adulto , Ansiedad/complicaciones , Ansiedad/psicología , Estudios Transversales , Trastorno Distímico/complicaciones , Trastorno Distímico/psicología , Femenino , Glutatión Peroxidasa/análisis , Glutatión Peroxidasa/sangre , Humanos , Peróxidos Lipídicos/análisis , Peróxidos Lipídicos/sangre , Menopausia/metabolismo , México , Persona de Mediana Edad , Psicometría/instrumentación , Psicometría/métodos , Autoimagen , Autoinforme , Superóxido Dismutasa/análisis , Superóxido Dismutasa/sangre , Encuestas y CuestionariosRESUMEN
Sigma (σ) receptors have generated a great deal of interest due to their possible role in psychosis, neuroprotection, and various other behaviors including addictive processes. Sigma receptors have been located in brain areas involved in motor functions, including the dopaminergic projections from the substantia nigra to the striatum. Evidence suggests that one of their major roles might be to regulate the activity of the glutamatergic system via the N-methyl-D-aspartate receptor. The sigma receptor agonist 1,3-di-o-tolyl-guanidine (DTG) was found to increase dopamine release in the striatum, nucleus accumbens, and prefrontal cortex, in a dose-dependent manner, after central as well as peripheral administration, suggesting a modulatory role of these receptors on the dopaminergic system. The present study examines whether chronic administration of the DTG sigma agonist induces neuromorphological and behavioral changes in neonatal ventral hippocampal lesioned (nVHL) rats as a neurodevelopmental model of schizophrenia. The results show that the DTG administration reduces the hyperlocomotor activity in nVHL rats and reverses the neuronal hypotrophy generated in nVHL rats in the prefrontal cortex, amygdala, and nucleus accumbens. Our results demonstrate that DTG, a sigma-1 receptor agonist, reverses some of the behavioral and neuromorphological effects of nVHL on the rat and supports the possibility that DTG may have beneficial effects in the management of symptoms of schizophrenia.
Asunto(s)
Anticonvulsivantes/uso terapéutico , Conducta Animal/efectos de los fármacos , Lesiones Encefálicas , Guanidinas/uso terapéutico , Hipocampo/patología , Análisis de Varianza , Animales , Animales Recién Nacidos , Lesiones Encefálicas/tratamiento farmacológico , Lesiones Encefálicas/patología , Lesiones Encefálicas/fisiopatología , Conducta Exploratoria/efectos de los fármacos , Hipocampo/ultraestructura , Masculino , Actividad Motora/efectos de los fármacos , Inhibición Prepulso/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Reflejo de Sobresalto/efectos de los fármacos , Tinción con Nitrato de PlataRESUMEN
PURPOSE: The 2015 Commission on Cancer standards require that cancer survivors receive an individualized survivorship care plan (SCP). To meet this new standard, St Luke's Mountain States Tumor Institute (MSTI), with support from the National Community Cancer Centers Program, implemented a successful survivorship model. PATIENTS AND METHODS: At MSTI, the patient's SCP is prepared in the electronic health record by a registered health information technician. This document is reviewed during an appointment with a nurse practitioner and social worker. The provider's dictation is mailed to the primary care physician with the SCP. From August 2011 to Oct 2012, 118 patients with breast cancer were seen for survivorship appointments. Medical record audit and follow-up telephone call were completed to evaluate patient survivorship needs and satisfaction with the appointment. Patient accounts were reviewed for reimbursement. RESULTS: From medical record review, the most common patient concerns were weight management (35%), fatigue (30%), sexuality (27%), anxiety (23%), caregiver stress (17%), and depression (16%). Telephone calls showed high patient satisfaction and understanding. Patients rated the following statements on a Likert scale from 1 (strongly disagree) to 5 (strongly agree): I understand my treatment summary and care plan (88% strongly agree or agree), and I feel the survivorship visit met my survivorship needs (86% strongly agree or agree). At 1 month, 80% of participants were still working on wellness goals. Patient accounts analysis showed revenue covered costs. CONCLUSION: Survivorship care at MSTI meets new standards, allows for patient engagement and satisfaction, and improves care coordination. Costs are covered by reimbursement.
Asunto(s)
Atención a la Salud , Costos de la Atención en Salud , Oncología Médica , Sobrevivientes , Neoplasias de la Mama/economía , Neoplasias de la Mama/terapia , Análisis Costo-Beneficio , Atención a la Salud/economía , Femenino , Encuestas de Atención de la Salud , Necesidades y Demandas de Servicios de Salud , Humanos , Reembolso de Seguro de Salud , Satisfacción del PacienteRESUMEN
BACKGROUND: Oxidative stress is a serious imbalance between the reactive oxygen species (ROS) produced and the antioxidant systems, and has been identified to cause metabolic syndrome. Postmenopausal women (POS) with severe symptoms have higher oxidative stress; therefore it is possible to observe higher oxidative stress in postmenopausal women with metabolic syndrome and severe menopause related symptoms. OBJECTIVE: To determinate if the severe postmenopausal symptoms increased oxidative stress in women with metabolic syndrome. METHODS: We carry out a cross-sectional study with POS, 48 with metabolic syndrome and 52 healthy. Control group was defined as women heealthy and without severe symptoms (H-SS). Metabolic syndrome was defined according to criteria established by NCEP-ATPIII. We measured lipoperoxides by the TBARS assay as oxidative stress marker. All women answered the Menopause Rating Scale (MRS) that evaluates the severity of global symptoms in three dimensions: psychological, somatic and urogenital; and the Athens Insomnia Scale (AIS). In each questionnaire was used a cutoff value to determine the severity of symptoms and alternative cut-off value for lipoperoxides > or =0.320 mol/L. RESULTS: The prevalence of high plasma lipoperoxides levels was higher in women with metabolic syndrome (WMS), 39 [81%] vs. 33 [64%], p < 0.05. The WMS, independent of severe symptoms (SS), had high lipoperoxides levels, similar to H+SS, except in urogenital MRS dimen- sion and AIS. The risk of higher lipoperoxides increased with MS and severe symptoms RM=6.32, 95% CI: 1.32-30.20, p < 0.05, adjusted by others pro-oxidants factors. CONCLUSION: Our findings suggest that the severity of menopausal related symptoms increased oxidative stress in women with metabolic syndrome.
Asunto(s)
Síndrome Metabólico/metabolismo , Estrés Oxidativo , Posmenopausia , Estudios Transversales , Femenino , Humanos , Persona de Mediana Edad , Índice de Severidad de la EnfermedadRESUMEN
BACKGROUND: Estrogen therapy has an antioxidant effect and improves quality of life. There is no report on estrogen therapy and quality of life in relation to oxidative stress. OBJECTIVE: To determine the effect of estrogen hormonal therapy on quality of life and oxidative stress in postmenopausal women. PATIENTS AND METHODS: We carried out a controlled clinical trial including 111 perimenopausal women (40 to 60 years old) living in Mexico City. Women were assigned into three groups: (1) control group, 39 premenopausal women; (2) 33 postmenopausal women receiving oral conjugated estrogens and medroxyprogesterone (0.625 mg/d plus medroxyprogesterone 5 mg/d for 10 days); (3) 33 postmenopausal women taking placebo pills. We measured at baseline and at six months biochemical markers of oxidative stress: lipoperoxides by TBARS assay, erythrocyte superoxide dismutase (SOD) and glutathione peroxidase (GPx) and total antioxidant status (TAS) with Randox Laboratories, Ltd. kits. We also applied the World Health Organization Quality of Life, Brief (WHOQoL-Brief). RESULTS: Levels of lipoperoxides were higher in postmenopausal women with low quality of life vs. premenopausal women with high quality of life (0.357 +/- 0.06 vs0.315 +/- 0.04 micromol/L, p <0.05). Plasma lipoperoxides diminished in women taking hormonal therapy with low quality of life after six months of treatment (0.357 +/- 0.06 vs. 0.293 +/- 0.08 micromol/L, p < 0.01); also, the proportion of women in therapy with basal high lipoperoxides and quality of life average-low diminished (p < 0.05). There were no differences in the other groups. CONCLUSION: Estrogen therapy improves quality of life and reduces lipoperoxides as oxidative stress biomarker in postmenopausal women.
Asunto(s)
Terapia de Reemplazo de Estrógeno , Estrógenos/farmacología , Estrés Oxidativo/efectos de los fármacos , Posmenopausia/metabolismo , Calidad de Vida , Adulto , Método Doble Ciego , Femenino , Humanos , Persona de Mediana EdadRESUMEN
OBJECTIVE: The aim of this study was to determine the influence of menopause (hypoestrogenism) as a risk factor for oxidative stress. METHODS: We carried out a cross-sectional study with 187 perimenopausal women from Mexico City, including 94 premenopausal (mean ± SD age, 44.9 ± 4.0 y; estrogen, 95.8 ± 65.7 pg/mL; follicle-stimulating hormone, 13.6 ± 16.9 mIU/mL) and 93 postmenopausal (mean ± SD age, 52.5 ± 3.3 y; estrogen, 12.8 ± 6.8 pg/mL; follicle-stimulating hormone, 51.4 ± 26.9 mIU/mL) women. We measured lipoperoxides using a thiobarbituric acid-reacting substance assay, erythrocyte superoxide dismutase and glutathione peroxidase activities, and the total antioxidant status with the Randox kit. An alternative cutoff value for lipoperoxide level of 0.320 µmol/L or higher was defined on the basis of the 90th percentile of young healthy participants. All women answered the Menopause Rating Scale, the Athens Insomnia Scale, and a structured questionnaire about pro-oxidant factors, that is, smoking, consumption of caffeinated and alcoholic beverages, and physical activity. Finally, we measured weight and height and calculated body mass index. RESULTS: The lipoperoxide levels were significantly higher in the postmenopausal group than in the premenopausal group (0.357 ± 0.05 vs 0.331 ± 0.05 µmol/L, P = 0.001). Using logistic regression to control pro-oxidant variables, we found that menopause was the main risk factor for oxidative stress (odds ratio, 2.62; 95% CI, 1.35-5.11; P < 0.01). We also found a positive correlation between menopause rating score, insomnia score, and lipoperoxides, and this relationship was most evident in the postmenopausal group (menopause scale, r = 0.327 [P = 0.001]; insomnia scale, r = 0.209 [P < 0.05]). CONCLUSIONS: Our findings suggest that the depletion of estrogen in postmenopause could cause oxidative stress in addition to the known symptoms.
Asunto(s)
Menopausia/sangre , Estrés Oxidativo , Adulto , Antioxidantes/análisis , Índice de Masa Corporal , Estudios Transversales , Eritrocitos/enzimología , Estrógenos/sangre , Femenino , Hormona Folículo Estimulante/sangre , Glutatión Peroxidasa/análisis , Humanos , Peróxidos Lipídicos/sangre , México , Persona de Mediana Edad , Factores de Riesgo , Superóxido Dismutasa/análisisRESUMEN
Resumen: Introducción La depresión cada día cobra mayor importancia, y se estima que en el año 2020 será la segunda causa de años de vida saludable perdidos a escala mundial y la primera en países desarrollados, por lo que el diagnóstico adecuado y oportuno permitirá brindar un manejo integral que incluya psicoterapia y tratamiento médico adecuado, lo que mejorará de manera significativa la calidad de vida y el pronóstico de estas personas. En atención primaria existe sub diagnóstico y retraso en la identificación de la depresión, por lo que, desde el inicio del tratamiento, impacta negativamente en el bienestar de los individuos, en la salud pública y en los costos directos e indirectos de los servicios sanitarios. Es frecuente que el médico de atención primaria considere como "causa" de la depresión las quejas de la vida cotidiana, la incapacidad para hacer frente al estrés familiar, el aislamiento social o el cambio de roles y los problemas financieros; por lo tanto la considera "justificada" y evita proporcionar tratamiento, cuando en realidad esta incapacidad suele ser ocasionada por la misma depresión. La depresión es uno de los padecimientos psicogeriátricos más frecuentes y en México su prevalencia global es de 9.5% en mujeres y 5% en hombres mayores de 60 años. En la mayoría de los casos no es diagnosticada por la presentación atípica de la misma o por la falsa creencia de que forma parte del envejecimiento normal, puesto que en el adulto mayor la depresión se puede esconder en síntomas somáticos, ya sea como manifestaciones del síndrome depresivo o porque a causa de éste se acentúan los síntomas de otras enfermedades concomitantes. Los síntomas cognitivos secundarios se presentan con más frecuencia en este grupo etario. Objetivo Proporcionar a los médicos de primer nivel de atención, una guía de práctica clínica con los elementos técnico-médicos suficientes que faciliten el diagnóstico y tratamiento integral de adultos mayores con depresión. Usuarios. La guía está dirigida a los médicos del primer nivel de atención. Población blanco. Hombres y mujeres de 60 años de edad en adelante. Método El estudio comprendió dos fases: el diseño y la validación de la guía clínica. Selección de evidencia 1. Las palabras clave para la búsqueda fueron: Depresión, adulto mayor, guías clínicas, prevalencia, atención primaria, valoración, tratamiento, riesgo de suicidio. 2. Bases de datos consultadas: Cochrane, Pub-Med y Medline, en el período de 1990-2006. 3. Se encontraron 26 referencias para depresión mayor en adulto mayor: ocho meta análisis de estudios clínicos aleatorizados, dos clínicos aleatorizados, uno de cohorte, 12 descriptivos no experimentales y tres artículos de libros (DSM-IV TR; CIE 10, Manual de psicogeriatría). 4. Categoría de evidencia y fuerza de recomendación, indica al usuario el origen de las recomendaciones emitidas. En el algoritmo de la guía clínica se identifican los conceptos o el sustento de cada una de las recomendaciones. En la presente guía el diagnóstico de depresión se fundamenta en la CIE 10 y su gradación podría ser comparable con la depresión mayor del DSM IV TR. Se incluye el diagnóstico diferencial, los criterios de referencia al psiquiatra, los lineamientos para el tratamiento farmacológico, psicoterapéutico y psicosocial; fase de inicio y fase de mantenimiento. Conclusión La guía de práctica clínica propuesta se basa en metodología rigurosa, da al médico elementos suficientes para realizar el diagnóstico oportuno, así como el tratamiento integral en adultos mayores con depresión, e incorpora criterios con base en evidencia científica que permitirán actualizarla y evaluar su solidez ante el surgimiento de nueva evidencia, manteniendo así su validez.
Summary: Introduction Depression is growing in importance every day. It is estimated that by the year 2020 it will be worldwide the second cause for the loss of healthy life years and the first in developed countries. Considering this, an adequate and opportune diagnosis will allow for a complete handling of the disorder. This should include adequate psychotherapy and medical treatment which will in turn improve significantly the prognosis and life quality of depressed individuals. In the primary care area, sub-diagnosis and delays to identify depression are common. These have a negative effect on the individuals' well-being, in public health and in the direct and indirect costs of health services. It is not uncommon for primary care practitioners to consider everyday complaints, the inability to cope with family stress, social isolation, role change and money problems as «causes ¼ for depression. Thus, they deem depression «justified ¼ and fail to offer treatment when actually this very inability is often caused by depression. Depression is among the most frequent psycho-geriatric ailments. In Mexico, its overall prevalence is 9.5% in women and 5% in men age 60 or more. In most instances, it goes undiagnosed given its atypical expression or the false belief which considers it part of the normal aging process. In the elderly, depression may conceal somatic symptoms, be it as expressions of the depressive syndrome or because these same symptoms aggravate symptoms from other concomitant diseases. Secondary cognitive symptoms are more frequent among this age group. Objective To provide physicians at primary care a guideline with enough technical-medical elements to facilitate the timely diagnosis and integral treatment of elderly with depression. Method This study comprised two phases: design and validation of the guideline. Evidence selection 1. Key words for search: depression, elderly, clinical guidelines, prevalence, primary care, assessment, treatment, suicide risk. 2. Data bases used: Cochrane, Pub-Med and Medline for the 1990-2006 period. 3. Twenty-six references for major depression in the elderly were found: eight random meta-analysis, two random clinical, one cohort, twelve descriptive non-experimental, and three book articles (DSM-IV[HRM1] TR; CIE 10, Psycho-geriatrics Manual). 4. Evidence category and strength of recommendation. This indicates the user about the origin of recommendations issued. In the algorithm from the clinical guide, the concepts or support for each recommendation are identified. In this guide, the diagnosis of depression is based on the CIE-10 and its ranking may be comparable to that for major depression in the DSM-IV TR. Differential diagnosis; criteria for referring a patient to the psychiatrist; guidelines for pharmacological, psychotherapeutic and psychosocial treatment; onset phase and maintenance phase are included. Thus, the clinical practice guide proposed is based on a strict methodology. It offers enough elements for the general practitioner to assess an opportune and complete treatment for elderly people with depression. In addition, it incorporates criteria based on scientific evidence, which will allow updating it, and evaluating its solidity in the face of new evidence, which will in turn maintain its validity.
RESUMEN
Psychological stress and environmental pollution are frequently associated to urban environment and oxidative stress (OxS). Likewise, OxS is a risk factor for cognitive impairment (CI) in the elderly. Therefore, we hypothesized that the prevalence of CI in subjects of the urban area could be higher than in those of the rural area, and linked to higher OxS. The aim of the study was to determine the relationship between OxS and CI in elderly individuals from rural and urban settings in Mexico. Plasmatic TBARS, plasma total antioxidant status, and the antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPx) were measured in 104 urban and 85 rural elderly individuals. Cognitive functions were evaluated through the Mini Mental State Examination. We found a greater proportion of subjects with OxS and CI in urban than in rural areas (25% vs. 9%), with an odds ratio of 5.67 (CI95% 1.14-38.02, p < 0.05). Our findings suggest that the elderly in urban areas have more OxS and a higher risk of developing CI compared with elderly individuals in a rural environment.